Process for the preparation of lipid free protein hydrolysates from ribbon fish

IN607496BActive Publication Date: 2026-10-28NITTE UNIV
0 Cites 0 Cited by

Patent Information

Application Number
IN202041023449
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-06-04
Publication Date
2026-10-28
Estimated Expiration
2040-06-04
Patent Text Reader

Abstract

Ribbon fish protein hydrolysate prepared by enzymatic hydrolysis contains 62.87% protein and 29.72% lipid (dry weight). We developed and optimized lipase treatment of fish protein hydrolysate to obtain lipid-free protein hydrolysate. Ribbon fish protein hydrolysate was prepared by aproteolytic enzyme treatment for 4h at pH 7 and 60oC. The resulting supernatant containing protein hydrolysate was further treated with lipase and the time and temperature of treatment was optimised. The result showed that the lipid content of the hydrolysate decreased from the initial value of 29.72% to nearly 0% depending on the enzyme concentration and the duration of the treatment. Since the lipid was removed, the protein content of the hydrolysate was found to increase from 62.87% to 94.11%. Lipase treatment did not change the DH% (p<0.05) in protein hydrolysates. The product showed ACE-1 inhibitory activity at half the concentration compared to the untreated product. Lipase treated hydrolysate showed in-vitro ACE-1 inhibitory activity of IC50 value ata lower concentration (0.20mg / mL) compared to untreated treated protein hydrolysates, which required 0.44mg / mL concentration. Electrophoresis data revealed that the molecular weight of peptides in both the samples was of the same size ranging from 12-85 KDa. The study showed that the lipase treatment of ribbon fish protein hydrolysate improved its bioactive properties.
Need to check novelty before this filing date? Find Prior Art

Claims

Claims:We claim thata. We have developed and optimised process for producing ribbon fish protein hydrolysate that is lipid-free.b. The process in claim “a” does not alter the peptide and amino acid content of the hydrolysatec. The process results in a product that shows antihypertensive activity in in vitro system at half the concentration compared to product before treatment. d. The process developed can be used to develop a product that is effective as a nutraceutical at half the concentration saving cost to the consumer. , Description:Description:Objective:Development of process for effective removal of lipid from ribbon fish protein hydrolysate and improvedantihypertensive activity.Highlights:Fish protein hydrolysateshave lipid content of 28-30% and this lowers the protein content as well as its ACE-I inhibitory activity per gram weight, thus making it less efficient as a functional food.We have, for the first time developed a process for producing lipid free protein hydrolysates with improved ACE-I inhibitory activity with non-significant change in physio-chemical parameters. The product is of commercial importance for its enhancedACE-I activity which can replace the synthetic drugs available for hypertension causing lot of side effects.Detailed Justification: Lage amount of trashfish or fish byproduct from the fish industries are dumped or discarded leading to waste disposal problems and environmental pollution.It is estimated by Food and Agriculture Organisation that 7.3 million tons of fish processing waste is discarded every year. Therefore, these byproducts are either used as fertilizer or as animal foods. Some previous studies have indicatedthat protein hydrolysates derived from fish proteins are potential source of bioactive peptides.Aminoacid composition and conformation of the proteins, method and conditions for their isolation, degree of purifications and processing alterations are some factors (in addition to pH and temperature) influencing the biological and functional properties of fish protein. Fish protein is rapidly gaining importance in nutritional supplementation because of their unique properties. We have used aproteolytic enzyme to hydrolyze fish and its waste to produce fish protein hydrolysates (FPH) under the optimum condition of pH and temperature. Enzymatic hydrolysis is similar to natural digestive process providing the most efficient breakdown of the proteins into smaller fractions of peptides, which is isolated from the oil by filtration and centrifugation. Enzymatically obtained FPH containing 2 - 20 amino acids can have a variety of applications in nutraceuticals, pharmaceutical products, cosmetics etc. Bioactive properties associated with protein hydrolysate have antioxidant, antihypertensive, immunomodulatory, neuroactive, antimicrobial, and mineral or hormone regulating properties. However, in this work, we have focused on the antihypertensive property of fish proteins hydrolysate and its peptides. Hypertension is one of the major risk factors causing cardiovascular diseases. Renin angiotensin plays key role in maintaining the blood pressure homeostasis as well as salt balance. Every year 17.7 and 6.7 million die of CVD and stroke respectively according to WHO statistics. The ability of some molecules to inhibit Angiotensin Converting Enzyme (ACE) is useful in therapeutic approach of treating hypertension. Many synthetic antihypertensive drugs such as captopril, enalapril etc. are commercially available. But these antihypertensive drugs havealso proven to cause many side effects like cough, taste disturbance, renal problem and angioneuricoedema. Due to the adverse health effect of the synthetic antihypertensive drugs, the search for safe natural antihypertensive agents such as those derived from fish protein is gaining importance. Antihypertensive component present in the food play significant role in protecting the body from hypertensive stress. Many researchers have worked on identifying and extracting the angiotensin-1 converting enzyme (ACE) inhibitor peptides by the various food materials. In recent years, fish protein sources particularly fish processing waste are considered as important potential sources of antihypertensive peptide. Fish protein hydrolysates contain approximately 24% of lipid content. Lipid content in fish protein hydrolysates lowers the protein content thus making it less efficient as a functional food. Fish protein hydrolysates having low lipid content and increased ACE-1 inhibitory activity have better potential as a nutraceutical. Hence,we developed and optimized a process for reduction of lipid content of ribbon fish protein hydrolysate and produce a product withenhanced ACE-1 inhibitory activity. The process developed by us isindicated in the Fig below.The final product has following specifications:Nutrients (%) Protein hydrolysate with lipids Lipid free protein hydrolysateMoisture 3.23±0.06 5.33±0.05Fat 29.72±1.26 0±0.00Protein 62.87±0.88 94.11±2.38Carbohydrates 0.22±0.02 0±0.00Ash (Total minerals) 3.96±0.21 0.56±0.21Degree of hydrolysis (DH) 24.24±2.26 26.82±1.86ACE-1 inhibitory activity (IC50) 0.44 mg / mL 0.20mg / mLThe result showed that the lipid content of the hydrolysate decreased from the initial value of 29.72% to nearly 0% depending on the enzyme concentration and the duration of the treatment. Since the lipid was removed, the protein content of the hydrolysate was found to increase from 62.87% to 94.11%. Lipase treatment did not change the DH% (p<0.05) in protein hydrolysates. On the other hand, lipase treated hydrolysate showed of IC50 value (concentration of inhibitory molecule required to inhibit 50% of ACE activity) at a lower concentration (0.20mg / mL) compared to untreated treated protein hydrolysates, which required 0.44mg / mL concentration. Electrophoresis data revealed that the molecular weight of peptides in both the samples was of the same size ranging from 12-85 KDa. The study showed that the lipase treatment of ribbon fish protein hydrolysate improved its bioactive properties.The product showed antihypertensive activity in vitro assay at half the concentration compared to the unprocessed hydrolysate. This would significantly reduce cost to the consumers.